Format

Send to

Choose Destination
See comment in PubMed Commons below
Vascular. 2012 Jun;20(3):156-65. doi: 10.1258/vasc.2011.201201. Epub 2012 Jun 14.

Biology of metabolic syndrome in a vascular patient.

Author information

1
The Methodist Hospital Research Institute, Houston, TX 77030, USA.

Abstract

Metabolic syndrome is highly prevalent in vascular patients and has a significant impact on the outcomes of vascular interventions. It comprises of a set of metabolically driven risk factors, including truncal obesity, dyslipidemia, elevated blood pressure and elevated fasting blood glucose. Increased insulin resistance within the context of obesity and hypertension contributes to atherogenic dyslipidemia, hyperglycemia, and prothrombotic and proinflammatory states which lead to the adverse impact of metabolic syndrome on the response to injury and on atherosclerotic disease progression. This review focuses on the complex biology of metabolic syndrome and its relevance to management of vascular patients, including outcomes and implications for the coronary, cerebrovascular and lower-extremity vascular beds.

PMID:
22700582
DOI:
10.1258/vasc.2011.201201
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center